Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
about
Asymmetric Dimethylarginine and Its Relation As a Biomarker in Nephrologic DiseasesEndothelial dysfunction: its role in hypertensive coronary disease.Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.Asymmetric dimethylarginine may be a missing link between cardiovascular disease and chronic kidney disease.Arginine dimethylation products in pediatric patients with chronic kidney disease.Assessment of endothelial dysfunction: the role of symmetrical dimethylarginine and proinflammatory markers in chronic kidney disease and renal transplant recipientsDoes uremia cause vascular dysfunction?Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.Metabolomic Profiling of Arginine Metabolome Links Altered Methylation to Chronic Kidney Disease Accelerated Atherosclerosis.The relationship of plasma ADMA levels with cardiac functions and metabolic parameters in peritoneal dialysis patients.Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation.Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population.Chronic NOS inhibition actuates endothelial-mesenchymal transformation.Markers of endothelial dysfunction and evaluation of vascular reactivity tests in Behçet disease.
P2860
Q28078222-D1E0208B-97F9-4F38-842C-0E34DA6809E2Q35581616-905A9E04-0A8C-4E93-BE5A-371DDA00AC17Q36018553-6F84A34B-6633-4E83-AD4D-BBFDA4AA6FABQ36997972-F7C38C0C-CCFE-448A-81F5-0B84EF050D6EQ37026363-1F56246D-7786-4468-BDE5-780DBC72CECBQ37176629-F8C058B9-55D7-40E2-8963-9FF2707A8F04Q37892318-D00FBA87-943C-40AE-9FC0-0FDE94715765Q38016491-896BAE20-B15C-40BB-A542-60BA0D206F78Q41979223-753E964C-6EEC-43AB-9E4B-FE61C6FA29D7Q42285086-A001A830-58DB-4F37-916D-04E4180196EFQ44796931-02DE88C2-68EB-486D-B3F0-F97B0896190EQ47676937-458C6D7F-2D09-4EEA-9A98-7AE69A7326B0Q50715902-710264E9-1AAD-4772-88EC-1AF8477A2E29Q54534540-A06F1880-E8DE-4185-A0B8-AE4A14925F5F
P2860
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
@ast
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
@en
type
label
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
@ast
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
@en
prefLabel
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
@ast
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
@en
P2093
P1476
Asymmetric dimethylarginine: a cardiovascular risk factor in renal disease?
@en
P2093
Danilo Fliser
Jan T Kielstein
Stefanie M Bode-Böger
P304
P356
10.1046/J.1523-1755.63.S84.11.X
P577
2003-05-01T00:00:00Z